临床 参数 | 治疗组(n = 36) | 对照组(n = 34) | 两组间治疗后比较 | |||||||
治疗前 | 治疗后 | t值 | P值 | 治疗前 | 治疗后 | t值 | P值 | t值 | P值 | |
EAT (mm) | 5.41 ± 1.72 | 3.74 ± 1.32 | 4.6215 | 0.0000 | 5.45 ± 1.79 | 4.86 ± 1.63 | 1.4622 | 0.1482 | −3.2039 | 0.0020 |
LAD (mm) | 44.2 ± 4.5 | 41.2 ± 4.1 | 2.9568 | 0.0042 | 44.9 ± 4.4 | 42.3 ± 4.3 | 2.4642 | 0.0163 | −1.0956 | 0.2771 |
LVDd (mm) | 61.1 ± 6.7 | 55.2 ± 5.1 | 4.2042 | 0.0001 | 60.9 ± 6.5 | 57.8 ± 5.4 | 2.0817 | 0.0413 | −2.1116 | 0.0384 |
LVEF (%) | 36.7 ± 5.2 | 49.3 ± 6.3 | −9.2547 | 0.0000 | 37.4 ± 5.5 | 45.2 ± 6.1 | −5.6246 | 0.0000 | 2.7636 | 0.0073 |
HbA1c (%) | 9.48 ± 2.23 | 7.13 ± 1.52 | 5.2246 | 0.0000 | 9.53 ± 2.19 | 7.96 ± 1.67 | 3.3240 | 0.0015 | −2.1766 | 0.0330 |
NT-proBNP (pg/mL) | 3873 ± 1132 | 1586 ± 560 | 10.8651 | 0.0000 | 3925 ± 1104 | 2394 ± 749 | 6.6916 | 0.0000 | −5.1307 | 0.0000 |
6MWT (m) | 264 ± 83 | 472 ± 127 | −8.1558 | 0.0000 | 271 ± 87 | 403 ± 108 | −5.5500 | 0.0000 | 2.4418 | 0.0086 |
MLWHFQ (分) | 2.96 ± 0.48 | 1.22 ± 0.24 | 19.0069 | 0.0000 | 2.93 ± 0.46 | 1.87 ± 0.32 | 11.1298 | 0.0000 | −9.6495 | 0.0000 |